Type 2 diabetes has long been framed as a story of calories, weight and willpower, but a growing body of research is shifting ...

A multi-species synbiotic supplement has led to measurable improvements in weight, metabolic control and cardiovascular risk ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

Medically reviewed by Danielle Weiss, MD Key Takeaways Diabetes can be easily misdiagnosed because its symptoms are similar ...

A recent study found a substantial time-dependent decrease in acute blood glucose levels (FBS and PPBS) in patients with type ...

The Phase 1b study is designed to evaluate the safety and tolerability of orally administered balomenib over a 28-day treatment period, followed by a post-treatment observation phase of up to ...

ENDO 2019 PIONEER-3: Oral Semaglutide Shows Benefit in Type 2 Diabetes Higher doses of oral semaglutide reduce HbA1c better than sitagliptin in type 2 diabetes but has more gastrointestinal side ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...